Literature DB >> 34353579

Hyperbilirubinemia in the Term Infant: Re-evaluating What We Think We Know.

Cathy Hammerman1, Michael Kaplan2.   

Abstract

This article attempts to highlight contemporary issues relating to term neonatal hyperbilirubinemia and to focus attention on controversial issues and concepts with the potential to effect change in clinical approach. On the one hand, the focus is bilirubin neurotoxicity, which is now known to encompass a wide, diverse spectrum of features. The various aspects of this spectrum are outlined and defined. On the other hand, bilirubin also possesses antioxidant properties. As such, mild hyperbilirubinemia is suggested as actually offering the neonate some protective advantage.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bilirubin; Hyperbilirubinemia; Neurologic damage; Term infant

Year:  2021        PMID: 34353579     DOI: 10.1016/j.clp.2021.05.006

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  1 in total

1.  Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.

Authors:  Emel Okulu; Omer Erdeve; Ilknur Kilic; Ozgur Olukman; Sebnem Calkavur; Gokhan Buyukkale; Merih Cetinkaya; Dilek Ulubas; Nihal Demirel; Deniz Hanta; Sabahattin Ertugrul; Nazli Dilay Gultekin; Oguz Tuncer; Nihat Demir; Leyla Bilgin; Nejat Narli; Duran Yildiz; Demet Terek; Ozge Altun Koroglu; Canan Seren; Elif Ozyazici; Ramazan Ozdemir; Hatice Turgut; Fatma Narter; Yasemin Akin; Ahmet Ozyazici; Aysegul Zenciroglu; Huseyin Selim Asker; Zeynel Gokmen; Musa Salihli; Ali Bulbul; Umut Zubarioglu; Begum Atasay; Esin Koc
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.